Introduction. Women with a history of preeclampsia have increased risk of cardiovascular disease later in life. However, it is unclear whether early gestational age at preeclampsia onset is associated with higher cardiovascular disease risk. This study aimed to test the association between gestational age at preeclampsia onset (including the early-onset/late-onset preeclampsia distinction) and subclinical atherosclerosis and arterial stiffness in age-matched women 12 years after index pregnancy. Material and methods. Eligible participants were identified in two Danish registries. Main outcome measures were carotid plaque presence, carotid intima-media thickness, aortic pulse wave velocity, and augmentation index adjusted for heart rate. Results. Twenty-four women with previous early-onset preeclampsia, 24 with previous late-onset preeclampsia and 24 with previous normotensive pregnancies were included after matching on age (AE2 years) and time since delivery (AE1 year). In all outcome measures, the early-onset group had the highest percentage or mean value. In the adjusted analysis, the early-onset group significantly differed from the late-onset group in all outcome measures except aortic pulse wave velocity. The early-onset group also had significantly higher carotid intima-media thickness (average and left) compared with the normotensive group. Gestational age at preeclampsia onset as a continuous variable was significantly associated to both carotid plaque presence and carotid intima-media thickness (average and right). Conclusions. Gestational age at preeclampsia onset is negatively associated with markers of subclinical atherosclerosis 12 years after delivery. Potentially, gestational age at preeclampsia onset might be helpful in directing cardiovascular disease prevention after preeclampsia.
Introduction
Preeclampsia is defined as new-onset of hypertension and proteinuria after 20 weeks of gestation or new-onset of other preeclampsia-associated maternal organ dysfunction in the absence of proteinuria (1, 2) . In addition to pregnancy-related risks, preeclampsia also implies maternal risk after delivery. Preeclamptic women have increased cardiovascular disease (CVD) risk later in life (3) (4) (5) . Clinical guidelines on post-preeclamptic CVD risk screening differ considerably. The British NICE guideline does not recommend CVD screening (6) . In contrast, the Norwegian NGF guideline recommends blood pressure monitoring of all previously preeclamptic women. Additionally, lifestyle information and perimenopausal CVD screening are recommended for women with severe forms of preeclampsia and/or early-onset disease (and therefore early delivery) (7) . The American ACOG guideline also focuses on preeclampsia subtypes and recommends yearly screening, but only if preeclampsia is complicated by recurrence or preterm delivery (2) .
The diverging guidelines result from insufficient knowledge about the preeclampsia-CVD association. Furthermore, the relative risk is significantly increased, but the absolute CVD risk for all previously preeclamptic women is still very low. Hence, as NGF and ACOG guidelines indicate, an emerging focus on CVD risk differences between preeclampsia subtypes has arisen. Researchers worldwide agree that several subtypes exist within the broad preeclampsia definition. Using the onset of clinical symptoms is one way to categorize preeclampsia. One of the most established subtype-distinctions is early-onset/ late-onset preeclampsia. By definition, early-onset preeclampsia occurs before 34 weeks of gestation and late-onset preeclampsia at or after 34 weeks of gestation (8) . Additionally, gestational age at preeclampsia onset can also be used as a continuous variable.
Gestational age at delivery affects CVD risk after preeclampsia, as preeclamptic women with preterm deliveries have an even higher risk (3) . However, only few studies have tested how gestational age at preeclampsia onset is associated with CVD risk later in life (9) (10) (11) (12) . At present, it is unclear whether gestational age at the clinical onset of preeclampsia can help identify previously preeclamptic women at highest CVD risk. We hypothesize that early gestational age at preeclampsia onset is associated with high risk of subclinical CVD in women who have not reached natural menopause. Hence, the aim of the study is to test the association between onset of preeclampsia (including the early-onset/late-onset distinction) and subclinical CVD in women giving birth in 1998-2008. Main outcome measures of subclinical CVD are markers of atherosclerosis [carotid plaque presence and carotid intima-media thickness (cIMT)] and arterial stiffness [aortic pulse wave velocity (aPWV) and augmentation index adjusted for heart rate (AIx-75)].
Material and methods
The source population was all pregnant women assigned to the Department of Obstetrics and Gynecology, Randers Regional Hospital, giving birth between 1998-2008. This period was expected to result in follow up paralleling mean follow up from large epidemiological studies (3, 5) .
During 1998-2008, preeclampsia diagnosis was defined as new-onset hypertension (systolic blood pressure ≥140 mmHg and/or diastolic blood pressure ≥90 mmHg) and proteinuria (≥300 mg/24 h or ≥30 mg/mmol albumin : creatinine random urine or ≥1 + on repeat dipstick). Early-onset preeclampsia was defined as symptoms occurring before 34 weeks of gestation and late-onset preeclampsia at or after 34 weeks of gestation (8) .
All preeclamptic women were identified in The National Patient Registry and The Medical Birth Registry using following ICD-10 diagnosis codes: DO14.0 Mild to moderate preeclampsia; DO14.1 Severe preeclampsia; DO14.2 HELLP syndrome and DO14.9 Preeclampsia, unspecified. The National Patient Registry provided the date of admission or outpatient treatment, whereas The Medical Birth Registry only provided date of birth. Preeclampsia onset was defined as gestational age at diagnosis (early-onset group, n = 17; late-onset group, n = 9). When specific gestational age at preeclampsia diagnosis was not obtainable, gestational age at admission was used (early-onset group, n = 3; late-onset group, n = 11). The latest possible preeclampsia onset was defined as gestational age at delivery (early-onset group, n = 4; late-onset group, n = 4). Eligible women with possible early-onset preeclampsia were identified from dates obtained from the registries and were invited to participate (in total, 55 women, Figure 1 ). For every early-onset woman, eligible women with late-onset preeclampsia and with normotensive pregnancies were identified after matching on age (AE 2 years) and time since delivery (AE 1 year).
Women were excluded if they at first examination were pregnant, breastfeeding, had reached natural menopause, or had moved more than 100 km away from the study site. Women with normotensive pregnancies were also excluded if they before or after index pregnancy experienced gestational hypertension, preeclampsia, HELLP syndrome or eclampsia. All eligible women were invited to participate in the current study by mail.
A high-resolution 9 MHz linear ultrasound transducer (attached to GE Vivid E9, GE Healthcare, Broendby, Denmark) was used to measure the two markers of subclinical atherosclerosis: carotid plaque presence and cIMT. Both
Key Message
Our study showed that early gestational age at preeclampsia onset is associated with subclinical atherosclerosis 12 years after delivery. This association was demonstrated examining gestational age at preeclampsia onset both as a continuous variable and categorized by the early-onset/late-onset distinction. markers were obtained from common carotid arteries and average, right and left cIMT were reported. The ultrasonography procedure followed the 2011 Mannheim Carotid Intima-Media Thickness and Plaque Consensus using semiautomated edge detection software providing up till 250 measurements on a 10-mm far wall segment (13) . On each side, the average of mean cIMT obtained from two different angles (anterior, lateral or posterior) was calculated. The entire carotid system was surveyed bilaterally for the presence of plaque. Presence of plaque was defined as a focal increase in cIMT above 1.5 mm visualized in both longitudinal and cross-sectional views. A single assessor performed all carotid ultrasound examinations. A single assessor conducted all carotid ultrasound examinations. Evaluating reliability, we used intra-class correlation coefficient (ICC) (14) . Indicating almost perfect agreement, our assessor demonstrated intra-examiner ICC = 0.93 examining 10 women at two separate occasions. A trained assessor (more than 250 carotid ultrasound scans) examined the same 10 women, which resulted in an inter-examiner ICC of 0.89 (15) . aPWV and AIx-75 were used as markers of arterial stiffness. Both markers were attained using the applanation tonometry with a SphygmoCor â device (Atcor, Sydney, Australia). The arterial stiffness examinations followed the recommendations of the 2011 Expert Consensus Document (16) . AIx-75 was presented as the mean value of two recordings. A single assessor conducted all arterial stiffness examinations and demonstrated intraexaminer ICC = 0.86. Inter-examiner ICC = 0.72 after a trained arterial stiffness assessor (more than 100 examinations) examined the same 10 women. Standardized interviews were completed for all participants. The revised 2013 Fenton growth chart for preterm infants was used to calculate small-for-gestational age (17) . Body mass index was calculated by dividing body weight (kg) by squared height (m) at first examination. Blood samples were drawn at the level of the antecubital vein and handled and analyzed according to standard laboratory protocols.
Blood pressure measurements were performed after 10 min rest in seated position using a fully automatic Figure 1 . Flowchart of participants with previous early-onset preeclampsia. 1 Four women had no contact information, and four women had moved more than 100 km away from the study site. oscillometric device (Omron MIT Elite; Omron Healthcare Co., Kyoto, Japan) with appropriate cuff size. Three measurements at 3-min intervals were performed. The mean value of the last two measurements was used in the analysis. The blood pressure measurements were repeated if the two last measurements differed more than 5 mmHg.
All statistical analyses were performed using STATA software version 13.1 (StataCorp, College Station, TX, USA). Normally distributed continuous variables were reported as mean (standard deviation) for descriptive data and as mean (95% confidence interval) for outcome measures. Binary variables were reported as absolute number (percentage). Statistically, overall differences between all three groups were first evaluated by analysis of variance (ANOVA) for continuous variables and Chi-square test for dichotomous variables. Logistic or linear regression models were also used to analyze associations between gestational age at diagnosis, the two matching variables and outcome measures. A priori, sample size was determined on the basis of a proportional difference of 15% in average aPWV. Average aPWV was considered the earliest CVD risk marker of the primary outcome measures. Using aPWV reference values from a healthy European population (mean = 7.5; standard deviation = 1.2), a minimum of 19 women per group was needed (80% power and 5% type I error) (18) .
Ethics approval
The Medical Ethics Committee, Central Denmark Region, approved the study protocol (ref. number 1-10-72-272-13) on 8 October 2013. The study protocol was also approved by the Danish Data Protection Agency and carried out according to the Declaration of Helsinki Principles. Before participation, verbal and written informed consent was obtained from each participant. The study was registered at: www.clinicaltrials.gov as NCT02337049.
Results
Twenty-four women with previous early-onset preeclampsia, 24 with previous late-onset preeclampsia, and 24 with previous normotensive pregnancies were included. Additional exclusions were made in the arterial stiffness analysis as one woman could not fully cooperate and another became pregnant (aPWV, n = 22; AIx-75, n = 23). Table 1 displays clinical characteristics at follow up. Although some differences were insignificant, the earlyonset group had highest mean values in all blood pressure variables. Notably, the early-onset group also had the most current smokers.
Index pregnancy characteristics are shown in Table 2 . The early-onset group differed significantly in many variables related to adverse pregnancy outcomes. However, the number of preeclampsia recurrences did not differ significantly between the early-onset and late-onset group.
Group comparisons of subclinical atherosclerosis and arterial stiffness markers are presented in Table 3 . Omnibus tests revealed no significant differences between the groups. Table 4 shows the results of the adjusted regression analysis. Using the normotensive group as reference, results were comparable to the group comparisons. However, statistically significant differences materialized between the early-onset and normotensive group in average cIMT and left cIMT (p = 0.04 and p = 0.04, respectively). Changing reference group provided significant differences between the early-onset and late-onset group in carotid plaque presence, cIMT (average, right and left) and AIx-75 (p < 0.05, p = 0.01, p < 0.05, p = 0.01 and p = 0.04, respectively). The early-onset/late-onset aPWV difference fell marginally short of significance (p = 0.06). Table 5 shows results of multivariate regression analysis testing the association between gestational age at diagnosis as continuous variable and main outcome measures. Statistically significant results materialized in carotid plaque presence and cIMT (average and right). All results showed the same trend; the earlier the preeclampsia onset, the higher the risk of subclinical atherosclerosis.
Furthermore, early preeclampsia onset was associated to lower gestational age at delivery. However, in multivariate regression analysis, associations between gestational age at delivery as a continuous variable and outcome measures were all insignificant (data not shown).
Discussion
In this observational cohort study, the gestational age at preeclampsia onset was negatively associated with subclinical atherosclerosis 12 years after delivery. This study examined the preeclampsia onset both as a continuous variable and categorized by the early-onset/late-onset distinction.
To our knowledge, this study was the first ever to find a significant negative association between gestational age at preeclampsia onset as a continuous variable and carotid plaque presence. Although the early-onset/late-onset distinction showed a similar trend, we only found an insignificant trend toward more carotid plaques in the early-onset group compared with the normotensive group. One other study showed a similar result (19) , but other studies found significantly more carotid plaques in women with previous preeclampsia than in women with previous normotensive pregnancies (20, 21) . Notably, all studies had a higher mean age at follow up and a larger sample size, but neither of the studies provided information about gestational age at preeclampsia onset.
We also demonstrated significant negative associations between preeclampsia onset and average cIMT in this study. No previous studies used preeclampsia onset as a continuous variable, but two studies found insignificant Data are given as mean (standard deviation) or number (percentage). GA, gestational age; SGA, small-for-gestational age. Table 3 . Markers of subclinical atherosclerosis and arterial stiffness.
Early-onset preeclampsia (n = 24)
Late-onset preeclampsia (n = 24)
Normotensive pregnancy (n = 24) p-value
Atherosclerosis
Carotid plaque presence, n (%)
6 (25) 1 (4) 2 (8) cIMT differences comparing women with previous very early preeclampsia onset (before 24 weeks of gestation) or women with previous severe early-onset preeclampsia with women with previous normotensive pregnancies (9, 12) . Both studies had a smaller sample size and shorter follow up compared with the present study. Prior studies comparing previously preeclamptic women to previously normotensive women showed conflicting results (19) (20) (21) (22) (23) . Again, in these studies, information about preeclampsia onset was not provided. Regarding markers of subclinical atherosclerosis, the study sample size needs to be addressed. The small sample size might have prevented observed differences from reaching statistical significance or resulted in wide 95% confidence intervals hampering significant conclusions. However, taking the small sample size into account, the overall trend in subclinical atherosclerotic markers seems evident.
Both carotid plaque presence and cIMT indicated a negative association between preeclampsia onset and atherosclerotic disease later in life. Early preeclampsia onset is also associated to adverse pregnancy outcomes (24) , which in turn are shown to increase future CVD risk (25) (26) (27) . So, applying gestational age at preeclampsia onset Data are given as odds ratio (95% confidence interval) based on logistic regression models and as b-coefficients (95% confidence interval) based on linear regression models. AIx-75, augmentation index adjusted for heart rate; aPWV, aortic pulse wave velocity; cIMT, carotid intima-media thickness. Data are given as odds ratio (95% confidence interval) based on logistic regression models and as b-coefficients (95% confidence interval) based on linear regression models. AIx-75, augmentation index adjusted for heart rate; aPWV, aortic pulse wave velocity; cIMT, carotid intima-media thickness.
might represent an alternative composite adjustment for preeclampsia and the related adverse pregnancy outcomes. Unfortunately, we were unable to check the isolated effect of preeclampsia onset on subclinical atherosclerotic markers because our study sample size prevented statistical adjustment for adverse pregnancy outcomes. Markers of arterial stiffness showed a blurry picture. Despite the early-onset group displaying the highest mean values in both aPWV and AIx-75, only differences between the early-onset and the late-onset group showed a trend in adjusted regression analysis. In this, our findings were only partly in line with the findings by Orabona and colleagues. The Orabona study revealed significant higher PWV and AIx-75 after early-onset preeclampsia than after either late-onset preeclampsia or normotensive pregnancies (11) . Although mean age at follow up in the Orabona study and ours (37 vs. 42 years) were comparable, mean age might in fact explain the different findings. Thus, a recent meta-analysis found that arterial stiffness differences were less pronounced when mean age exceeded 40 years (28) . Studies of women with a mean age of 36-41 years found both aPWV and AIx-75 to be high in previously preeclamptic women; however, compared with women with previous normotensive pregnancies, differences were insignificant (15, 23, 29) . Underlining the contradictory results, our study found no significant association between preeclampsia onset as a continuous variable and markers of arterial stiffness Thus, the possible association between preeclampsia onset or preeclampsia in general seems to be very complex and only partially clarified.
Additional strengths and limitations need mentioning. In this study, gestational age at preeclampsia was rigidly controlled from two different registries. The rigid control surely minimized the chance of misclassification. Moreover, due to the design, no more than a two-year age difference was accepted between matched women from the early-onset, the late-onset and the normotensive group. Considering the well-known positive association between age and CVD, the design undoubtedly reduced confounding by age. The small sample size should be considered in relation to the different smoking habits. The current smoking differences might have affected our main outcome measures, leading to better outcomes for the lateonset group and poorer outcomes for the early-onset and normotensive group. Unfortunately, the study sample size was too small to systematically adjust for current smoking. Finally, this study focused solely on gestational age at preeclampsia onset as a possible CVD risk-stratifying tool. Owing to retrospective study design, no pre-pregnancy health information was obtainable. Hence, this study contributed no new knowledge on the pathophysiology linking preeclampsia and CVD.
Broadening the perspective, epidemiological studies support the general association between preeclampsia and CVD (3) (4) (5) . So far, epidemiological evidence of the association between gestational age at preeclampsia onset and future CVD risk is weak. Although failing to apply the exact early-onset/late-onset distinction, Mongraw-Chaffin and colleagues showed that gestational onset of preeclampsia significantly affected risk of CVD death 30 years after deliveries (10) . Compared with women without hypertensive disorders of pregnancy, CVD death hazard ratio reached 9.54 following preeclampsia diagnosed before or at 34 weeks of gestation and 2.08 following preeclampsia diagnosed after 34 weeks of gestation. Despite a distinctly different study design, the findings of both Mongraw-Chaffin and colleagues and the present study suggest that gestational age at preeclampsia onset is negatively associated with CVD risk. However, the pathophysiology of preeclampsia is only partly understood, so any categorical preeclampsia onset subdivision will be somewhat arbitrary. Further research is needed to explore the association between gestational age at preeclampsia onset as a continuous variable and future CVD.
In conclusion, our results showed that gestational age at preeclampsia onset including the early-onset/late-onset distinction was associated with subclinical atherosclerosis 12 years after delivery. Comparing women with previous early-onset preeclampsia with women with previous lateonset demonstrated statistically significant differences in nearly all outcome measures. However, the adjacent 95% confidence intervals were wide. Additionally, gestational age at preeclampsia onset as a continuous variable was significantly associated with carotid plaque presence and cIMT (average and right). In contrast, no statistically significant associations were found between gestational age at delivery and outcome measures. Interestingly, gestational age at delivery, but not gestational age at preeclampsia onset, is routinely registered in clinical practice. Clearly, large-scale studies are needed to further investigate the association between gestational age at preeclampsia onset and CVD risk later in life. Potentially, gestational age at preeclampsia onset may be helpful in directing CVD prevention after preeclampsia.
